Inviragen, Inc.

Takeda Pharmaceutical Co. Ltd. and India's Zydus Cadila have announced a "broad-based" agreement to develop a vaccine for chikungunya. The deal encompasses early stage development to final comme

Takeda Pharmaceutical Co. Ltd. has begun dosing in an international Phase III clinical program with its candidate prophylactic vaccine for dengue, TAK-003, closing the gap on the only commercialized

The first dosing in a new Phase IIb, placebo-controlled trial with Takeda Pharmaceutical Co. Ltd. 's bivalent vaccine for norovirus marks the first large-scale study anywhere for a candidate to pro

SHANGHAI - Sinovac Biotech Ltd., a Nasdaq-listed Chinese biopharmaceutical developer, expects to launch its original Enterovirus 71 (EV71) prophylactic vaccine for human hand, foot and mouth disease